| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| imfinzi biggest competitor in survival rates | 2 | 0.6 | 2642 | 35 | 44 |
| imfinzi | 0.61 | 1 | 2636 | 56 | 7 |
| biggest | 1.87 | 0.1 | 1798 | 89 | 7 |
| competitor | 0.66 | 0.7 | 1599 | 15 | 10 |
| in | 0.05 | 0.1 | 3065 | 47 | 2 |
| survival | 0.46 | 0.8 | 7923 | 35 | 8 |
| rates | 1.36 | 0.2 | 6868 | 52 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| imfinzi biggest competitor in survival rates | 0.12 | 0.9 | 2027 | 73 |
| imfinzi biggest competitor in cost | 0.17 | 0.4 | 738 | 62 |
| imfinzi biggest competitor in market share | 1.12 | 0.3 | 2136 | 92 |
| imfinzi biggest competitor in clinical trials | 1.43 | 0.2 | 834 | 57 |
| imfinzi biggest competitor in oncology | 0.2 | 0.6 | 9633 | 89 |
| imfinzi biggest competitor in side effects | 1.46 | 0.6 | 7872 | 72 |
| imfinzi biggest competitor in immunotherapy | 1.38 | 0.2 | 3832 | 1 |
| imfinzi biggest competitor in lung cancer | 1.99 | 0.5 | 8968 | 65 |
| imfinzi durvalumab biggest competitor in cost | 1.84 | 0.7 | 344 | 83 |
| imfinzi durvalumab biggest competitor | 1.22 | 0.5 | 80 | 73 |
| imfinzi biggest competitor in bladder cancer | 1.83 | 0.5 | 5126 | 9 |
| how effective is imfinzi | 1.44 | 0.2 | 8349 | 28 |
| imfinzi durvalumab biggest comparison | 1.95 | 0.6 | 7036 | 97 |
| how much does imfinzi cost | 0.32 | 0.2 | 5010 | 94 |
| imfinzi durvalumab biggest challenge | 1.38 | 0.1 | 4525 | 43 |
